Winfried Krueger

机构：Miltenyi Biotec (Germany), Lentigen Technology (United States) · ORCID：0000-0002-1269-9926

发表论文 46 篇 · 总被引 2442 次 · h-index 24

代表论文

• Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial (2020 · Nature Medicine · 被引 467)
• Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model (2019 · Science Translational Medicine · 被引 163)
• Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models (2021 · Science Translational Medicine · 被引 147)
• Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma (2020 · Frontiers in Immunology · 被引 101)
• A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy (2019 · Frontiers in Immunology · 被引 87)
• Epigenetic regulatory mechanisms during preimplantation development (2009 · Birth Defects Research Part C Embryo Today Reviews · 被引 79)